Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021

SELL
$6.05 - $10.41 $17,847 - $30,709
-2,950 Closed
0 $0
Q2 2021

Jul 08, 2021

SELL
$6.66 - $10.92 $9,990 - $16,380
-1,500 Reduced 33.71%
2,950 $27,000
Q1 2021

Jun 17, 2021

BUY
$4.59 - $18.74 $4,590 - $18,740
1,000 Added 28.99%
4,450 $39,000
Q4 2020

May 19, 2021

BUY
$3.93 - $5.5 $13,558 - $18,975
3,450 New
3,450 $31,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $510M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.